Approximately 20% to 30% of men with prostate cancer experience disease recurrence within 5 years of therapeutic intervention. 1 A key challenge in managing these patients is a scarcity of accurate ...
Jairam Eswara, MD, FACS, is a nationally recognized urology specialist and a Fellow of the American College of Surgeons. He’s the Chair of the Department of Urology at Tufts Medical Center and an ...
A large screening trial showed that using prostate-specific antigen density (PSAD) before MRI prevented overdiagnosis and lowered resource use while preserving the detection of clinically significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback